×
Jin Medical Pre-Tax Profit Margin 2023-2024 | ZJYL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Jin Medical pre-tax profit margin from 2023 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
View More
Jin Medical Pre-Tax Profit Margin 2023-2024 | ZJYL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Jin Medical pre-tax profit margin from 2023 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$196.8B
Stryker (SYK)
$146.2B
Boston Scientific (BSX)
$145.4B
EssilorLuxottica (ESLOY)
$115.4B
Medtronic (MDT)
$112.9B
Lonza Group Ag (LZAGY)
$43.8B
Haleon (HLN)
$41.8B
GE HealthCare Technologies (GEHC)
$38.7B
ResMed (RMD)
$35.2B
Terumo (TRUMY)
$28B
Koninklijke Philips (PHG)
$24.3B
Zimmer Biomet Holdings (ZBH)
$21.8B
Insulet (PODD)
$19.3B
Baxter (BAX)
$15.8B
Smith & Nephew SNATS (SNN)
$11.1B
Bio-Rad Laboratories (BIO)
$9.6B
BellRing Brands (BRBR)
$9.3B
Demant (WILYY)
$8.7B
Lantheus Holdings (LNTH)
$6.4B
ICU Medical (ICUI)
$4B
Prestige Consumer Healthcare (PBH)
$3.9B
Haemonetics (HAE)
$3.7B
Envista Holdings (NVST)
$3.4B
Perrigo (PRGO)
$3.3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.8B
GN Store Nord (GNNDY)
$2.6B
Neogen (NEOG)
$2.5B
LeMaitre Vascular (LMAT)
$2.2B
AtriCure (ATRC)
$1.9B